LIVN
LivaNova PLC
Key Financials
Gross Profit
$939.9M
↑ 334.6%
Net Income
$-242471000
↓ 483.5%
Operating Income
$199.4M
↑ 54.5%
Revenue
$1.4B
↑ 10.7%
Total Assets
$2.6B
↑ 4.0%
Cash & Equivalents
$635.6M
↑ 48.2%
EPS (Diluted)
$-4.45
↓ 483.6%
Shareholders' Equity
$1.2B
↓ 9.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LIVN |
| Company Name | LivaNova PLC |
| CIK | 1639691 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | 4402033250662 |